-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Initiates Coverage On Faeth Therapeutics with Buy Rating

Benzinga·09/09/2026 14:30:34
语音播报
TD Cowen analyst Tara Bancroft initiates coverage on Faeth Therapeutics (NASDAQ:FTH) with a Buy rating.